DOI:
10.1055/s-00025479
Experimental and Clinical Endocrinology & Diabetes Reports
LinksClose Window
References
Neggers SJ, de Herder WW, Janssen JA. et al.
Combined treatment for acromegaly with long-acting somatostatin analogs and pegvisomant: Long-term safety for up to 4.5 years (median 2.2 years) of follow-up in 86 patients.
Eur J Endocrinol 2009;
160: 529-533
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.